Mary Bridget Walsh is named as a lobbyist on federal disclosure filings for 1 client through Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, INC. The most recent filing naming them posted in January 2025. Issues reported include Health Issues, Medicare/Medicaid, Animals and Budget/Appropriations.
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Mary Bridget Walsh. See the Capitol Clarity rankings and method.
